The ITA reports that Italian athlete Vincenzo Tomasello has accepted a 14-month period of ineligibility
THE ITA, ON BEHALF OF IRONMAN, HEREBY REPORTS THAT ITALIAN ATHLETE VINCENZO TOMASELLO HAS COMMITTED AN ANTI-DOPING RULE VIOLATION (ADRV) UNDER ARTICLE 2.1 OF THE IRONMAN ANTI-DOPING RULES (IRONMAN ADR) FOR THE PRESENCE OF PREDNISOLONE AND PREDNISONE IN A SAMPLE COLLECTED IN-COMPETITION BY IRONMAN ON 25 NOVEMBER 2022 IN THE SCOPE OF THE 2022 IRONMAN ISRAEL. VINCENZO TOMASELLO PARTICIPATED IN THE EVENT IN THE AGE GROUP CATEGORY.
The sample collected from Vincenzo Tomasello returned an adverse analytical finding for the specified prohibited substances prednisolone and prednisone. Both substances are prohibited in-competition only and when administered via specific routes under the World Anti-Doping Agency’s Prohibited List as glucocorticoids (S9). Glucocorticoids are used for pain-relief and anti-inflammation.
After review of the case file, the ITA found that a fourteen (14) month period of ineligibility pursuant to article 10.6.1.1. IRONMAN ADR1 and disqualification of results from the 2022 IRONMAN Israel (25 November 2022) going forward were the applicable consequences. Mr Vincenzo accepted the consequences proposed by the ITA and the case was resolved via an acceptance of consequences pursuant to article 8.3.1 of the IRONMAN ADR. Since the athlete had accepted a voluntary provisional suspension pending the resolution of his case, the athlete’s period of ineligibility across all sports runs until 26 May 2024.
- Anti-Doping Anti-Doping Rule Violation (ADRV) International Testing Agency (ITA) World Anti-Doping Agency (WADA)
Global Summit 2024